UroGen Pharma Ltd. Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
UroGen Pharma Ltd. quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • UroGen Pharma Ltd. Return On Assets for the quarter ending September 30, 2024 was -47.9 %, a 38.7% increase year-over-year.
  • UroGen Pharma Ltd. annual Return On Assets for 2023 was -70.5 %, a 7.56% increase from 2022.
  • UroGen Pharma Ltd. annual Return On Assets for 2022 was -76.3 %, a 13% increase from 2021.
  • UroGen Pharma Ltd. annual Return On Assets for 2021 was -87.7 %, a 0.64% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -70.5 +5.76 +7.56% Jan 1, 2023 Dec 31, 2023
2022 -76.3 +11.4 +13% Jan 1, 2022 Dec 31, 2022
2021 -87.7 -0.56 -0.64% Jan 1, 2021 Dec 31, 2021
2020 -87.1 -41.4 -90.5% Jan 1, 2020 Dec 31, 2020
2019 -45.7 +19.1 +29.4% Jan 1, 2019 Dec 31, 2019
2018 -64.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.